evans blue has been researched along with Muscle Relaxation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bültmann, R; Ganter, C; Kurz, G; Pause, B; Starke, K; Wittenburg, H | 1 |
| Buckner, PS; John, E; Lui, K; Todd, DA | 1 |
2 other study(ies) available for evans blue and Muscle Relaxation
| Article | Year |
|---|---|
P2-purinoceptor antagonists: II. Blockade of P2-purinoceptor subtypes and ecto-nucleotidases by compounds related to Evans blue and trypan blue.
Topics: Adenosine Diphosphate; Adenosine Triphosphatases; Adenosine Triphosphate; Animals; Colon; Evans Blue; Guinea Pigs; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; Purinergic P2 Receptor Antagonists; Rats; Structure-Activity Relationship; Thionucleotides; Trypan Blue; Vas Deferens | 1996 |
Effect of short-term muscle relaxation on neonatal plasma volume.
Topics: Evans Blue; Female; Hematocrit; Humans; Infant, Newborn; Male; Muscle Relaxation; Pancuronium; Plasma Volume; Prospective Studies; Respiration, Artificial; Spectrophotometry; Time Factors | 1991 |